Hanall Biopharma, Active Community... Stock Price -20.9%.
At this time, posts about HanAll Biopharma are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 211,591 shares of HanAll Biopharma, and institutions have sold a net 1,244,000 shares, according to provisional data. HanAll Biopharma is known as an R&D-focused pharmaceutical and bio company.
As of 1:30 PM on the 3rd, HanAll Biopharma's stock price is 25,350 KRW, down 20.9% from the previous day, with a trading volume of 13,740,875 shares, which is 4,467.36% of the 5-day average trading volume.
In addition to HanAll Biopharma, posts by investors are also surging for Gooyoung Tech (053270), iMBC (052220), and YJM Games (193250).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
※ Source: AI Investment Assistant AI Racciro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
